During the past decade, National Eye Institute (NEI) conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Eye Institute (NEI)" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Eye Institute (NEI)" are "Uveitis" (14 trials), "Cataract" (8 trials), "Macular Degeneration" (8 trials), "Healthy" (6 trials) and "Diabetic Retinopathy" (5 trials). Many other conditions were trialed in "National Eye Institute (NEI)" in a lesser frequency.

Most popular intervention types in "National Eye Institute (NEI)" are "Drug" (25 trials), "Procedure" (6 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Daclizumab" (3 trials), "Vitamin E" (3 trials), "Triamcinolone Acetonide" (2 trials), "Angiography" (1 trials) and "Anodal stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Eye Institute (NEI)" are 63 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "National Eye Institute (NEI)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 62 completed trials in National Eye Institute (NEI), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Eye Institute (NEI), 14 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".